• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Jun 18;15(1):5175.
doi: 10.1038/s41467-024-49487-4. Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

Ruipeng Lei[SUP] #[/SUP][SUP] 1 [/SUP], Weiwen Liang[SUP] #[/SUP][SUP] 2 [/SUP], Wenhao O Ouyang[SUP] #[/SUP][SUP] 1 [/SUP], Andrea Hernandez Garcia[SUP] #[/SUP][SUP] 1 [/SUP], Chika Kikuchi[SUP] 3 4 [/SUP], Shengyang Wang[SUP] 3 4 [/SUP], Ryan McBride[SUP] 3 4 [/SUP], Timothy J C Tan[SUP] 5 [/SUP], Yuanxin Sun[SUP] 6 7 [/SUP], Chunke Chen[SUP] 6 7 [/SUP], Claire S Graham[SUP] 1 [/SUP], Lucia A Rodriguez[SUP] 1 [/SUP], Ivana R Shen[SUP] 1 [/SUP], Danbi Choi[SUP] 1 [/SUP], Roberto Bruzzone[SUP] 2 8 9 [/SUP], James C Paulson[SUP] 3 4 [/SUP], Satish K Nair[SUP] 1 5 10 [/SUP], Chris K P Mok[SUP] 11 12 13 14 [/SUP], Nicholas C Wu[SUP] 15 16 17 18 [/SUP]



Affiliations
Abstract

The receptor-binding site of influenza A virus hemagglutinin partially overlaps with major antigenic sites and constantly evolves. In this study, we observe that mutations G186D and D190N in the hemagglutinin receptor-binding site have coevolved in two recent human H3N2 clades. X-ray crystallography results show that these mutations coordinately drive the evolution of the hemagglutinin receptor binding mode. Epistasis between G186D and D190N is further demonstrated by glycan binding and thermostability analyses. Immunization and neutralization experiments using mouse and human samples indicate that the evolution of receptor binding mode is accompanied by a change in antigenicity. Besides, combinatorial mutagenesis reveals that G186D and D190N, along with other natural mutations in recent H3N2 strains, alter the compatibility with a common egg-adaptive mutation in seasonal influenza vaccines. Overall, our findings elucidate the role of epistasis in shaping the recent evolution of human H3N2 hemagglutinin and substantiate the high evolvability of its receptor-binding mode.


 
Back
Top